Cocrystal Pharma to Present at Virtual NobleCon17 Conference on January 19, 2021

Rhea-AI Summary

Cocrystal Pharma (Nasdaq: COCP), a clinical-stage biotechnology company, will present at NobleCon17 on January 19, 2021, at 2:15 p.m. ET. This annual investor conference focuses on innovative pharmaceutical developments, specifically novel antiviral therapeutics. The live presentation can be accessed at www.noblecon17.com, with a high-definition video available post-event on Cocrystal's website starting January 20, 2021. Cocrystal specializes in antiviral drugs targeting influenza, hepatitis C, coronaviruses, and noroviruses.

BOTHELL, Wash., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces that management will present at NobleCon17, Noble Capital Markets’ 17^th Annual Investor Conference on Tuesday, January 19, 2021 at 2:15 p.m. Eastern time (11:15 a.m. Pacific time).

The live presentation will be available at www.noblecon17.com. A high-definition video webcast of the presentation will be available beginning January 20, 2021 on the Investors section of the Cocrystal website here.

Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Investor Contact:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

# # #

FAQ

What is the significance of Cocrystal Pharma's presentation at NobleCon17?

Cocrystal Pharma's presentation at NobleCon17 showcases its commitment to developing novel antiviral therapeutics, which may attract investor interest and highlight its innovative research.

When is Cocrystal Pharma presenting at NobleCon17?

Cocrystal Pharma is presenting at NobleCon17 on January 19, 2021, at 2:15 p.m. Eastern time.

Where can I watch the Cocrystal Pharma presentation?

The presentation can be watched live at www.noblecon17.com, with a high-definition video available on Cocrystal’s website starting January 20, 2021.

What does Cocrystal Pharma specialize in?

Cocrystal Pharma specializes in discovering and developing novel antiviral therapeutics targeting influenza viruses, hepatitis C, coronaviruses, and noroviruses.

What is the ticker symbol for Cocrystal Pharma?

The ticker symbol for Cocrystal Pharma is COCP, listed on Nasdaq.